Cargando…
A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142394/ https://www.ncbi.nlm.nih.gov/pubmed/34084502 http://dx.doi.org/10.1002/ccr3.4084 |
_version_ | 1783696541103423488 |
---|---|
author | Heck, Johannes Seifert, Johanna Stichtenoth, Dirk O. Schroeder, Christoph Groh, Adrian Szycik, Gregor R. Degner, Detlef Adamovic, Ivana Schneider, Michael Glocker, Catherine Rüther, Eckart Bleich, Stefan Grohmann, Renate Toto, Sermin |
author_facet | Heck, Johannes Seifert, Johanna Stichtenoth, Dirk O. Schroeder, Christoph Groh, Adrian Szycik, Gregor R. Degner, Detlef Adamovic, Ivana Schneider, Michael Glocker, Catherine Rüther, Eckart Bleich, Stefan Grohmann, Renate Toto, Sermin |
author_sort | Heck, Johannes |
collection | PubMed |
description | Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety. |
format | Online Article Text |
id | pubmed-8142394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81423942021-06-02 A case series of serious and unexpected adverse drug reactions under treatment with cariprazine Heck, Johannes Seifert, Johanna Stichtenoth, Dirk O. Schroeder, Christoph Groh, Adrian Szycik, Gregor R. Degner, Detlef Adamovic, Ivana Schneider, Michael Glocker, Catherine Rüther, Eckart Bleich, Stefan Grohmann, Renate Toto, Sermin Clin Case Rep Case Reports Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety. John Wiley and Sons Inc. 2021-05-04 /pmc/articles/PMC8142394/ /pubmed/34084502 http://dx.doi.org/10.1002/ccr3.4084 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Heck, Johannes Seifert, Johanna Stichtenoth, Dirk O. Schroeder, Christoph Groh, Adrian Szycik, Gregor R. Degner, Detlef Adamovic, Ivana Schneider, Michael Glocker, Catherine Rüther, Eckart Bleich, Stefan Grohmann, Renate Toto, Sermin A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title | A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title_full | A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title_fullStr | A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title_full_unstemmed | A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title_short | A case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
title_sort | case series of serious and unexpected adverse drug reactions under treatment with cariprazine |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142394/ https://www.ncbi.nlm.nih.gov/pubmed/34084502 http://dx.doi.org/10.1002/ccr3.4084 |
work_keys_str_mv | AT heckjohannes acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT seifertjohanna acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT stichtenothdirko acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT schroederchristoph acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT grohadrian acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT szycikgregorr acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT degnerdetlef acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT adamovicivana acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT schneidermichael acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT glockercatherine acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT ruthereckart acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT bleichstefan acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT grohmannrenate acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT totosermin acaseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT heckjohannes caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT seifertjohanna caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT stichtenothdirko caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT schroederchristoph caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT grohadrian caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT szycikgregorr caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT degnerdetlef caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT adamovicivana caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT schneidermichael caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT glockercatherine caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT ruthereckart caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT bleichstefan caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT grohmannrenate caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine AT totosermin caseseriesofseriousandunexpectedadversedrugreactionsundertreatmentwithcariprazine |